AURA - Company ID 0001501796
The table below shows Aura Biosciences, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $59.52M | $31.69M | $41.06M | $121.58M | $149.06M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $149.74M | $160.62M | $231.79M | $196.70M | $153.70M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $2.62M | $3.21M | $3.15M | $5.37M | $5.25M |
| Goodwill | - | - | - | - | - |
| Total assets | $169.43M | $182.50M | $255.07M | $223.94M | $160.03M |
| Accounts payable | $1.55M | $2.30M | $1.79M | $2.92M | $2.40M |
| Total current liabilities | $18.38M | $14.91M | $12.36M | $10.46M | $7.27M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $32.52M | $30.53M | $29.23M | $28.35M | $7.71M |
| Retained earnings | -$480.42M | -$374.23M | -$287.31M | -$210.90M | -$152.14M |
| Total equity | $136.91M | $151.97M | $225.85M | $195.58M | $152.31M |